Jipei Liao

1.5k total citations
20 papers, 1.2k citations indexed

About

Jipei Liao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jipei Liao has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jipei Liao's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (5 papers). Jipei Liao is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (5 papers). Jipei Liao collaborates with scholars based in United States and China. Jipei Liao's co-authors include Feng Jiang, Jun Shen, Maria Guarnera, Lei Yu, Kaiissar Mannoor, Yuping Mei, Ruiyun Li, Howard Zhang, Nevins W. Todd and Zhenqiu Liu and has published in prestigious journals such as British Journal of Cancer, Molecular Cancer and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Jipei Liao

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jipei Liao United States 12 1.0k 918 143 129 32 20 1.2k
Linda Fabris United States 14 581 0.6× 477 0.5× 112 0.8× 196 1.5× 12 0.4× 19 803
Zhi‐Xuan Li China 12 745 0.7× 571 0.6× 68 0.5× 160 1.2× 12 0.4× 28 945
Anna Sanchez Calle Japan 12 712 0.7× 546 0.6× 54 0.4× 282 2.2× 81 2.5× 15 909
Wataru Okajima Japan 17 685 0.7× 582 0.6× 179 1.3× 211 1.6× 13 0.4× 27 982
Verónica Torrano Spain 15 645 0.6× 233 0.3× 84 0.6× 117 0.9× 34 1.1× 20 772
Yuanhe Wang China 12 374 0.4× 311 0.3× 82 0.6× 150 1.2× 16 0.5× 43 576
Mahito Miyamae Japan 19 761 0.7× 649 0.7× 212 1.5× 230 1.8× 15 0.5× 31 1.1k
Anna Aakula Finland 9 616 0.6× 462 0.5× 129 0.9× 71 0.6× 9 0.3× 11 733
Mengying Cui China 9 409 0.4× 409 0.4× 53 0.4× 99 0.8× 21 0.7× 14 585

Countries citing papers authored by Jipei Liao

Since Specialization
Citations

This map shows the geographic impact of Jipei Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jipei Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jipei Liao more than expected).

Fields of papers citing papers by Jipei Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jipei Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jipei Liao. The network helps show where Jipei Liao may publish in the future.

Co-authorship network of co-authors of Jipei Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Jipei Liao. A scholar is included among the top collaborators of Jipei Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jipei Liao. Jipei Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liao, Jipei, et al.. (2024). Improving CT scan for lung cancer diagnosis with an integromic signature. Journal of Biological Methods. 11(3). e99010023–e99010023. 1 indexed citations
3.
Zhou, Huifen, et al.. (2023). Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection. Microorganisms. 11(3). 582–582. 12 indexed citations
4.
Yang, Zejia, Jipei Liao, Lisa M. Schumaker, et al.. (2022). Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology. 131. 105939–105939. 8 indexed citations
5.
Yang, Zejia, Jipei Liao, Rena G. Lapidus, et al.. (2022). Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. 89(4). 469–478. 4 indexed citations
6.
Liao, Jipei, Zejia Yang, Brandon Carter‐Cooper, et al.. (2020). Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition. Clinical & Experimental Metastasis. 37(2). 283–292. 15 indexed citations
7.
Yang, Zejia, Jipei Liao, Kevin J. Cullen, & Hancai Dan. (2020). Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma. Cell Death Discovery. 6(1). 36–36. 11 indexed citations
8.
Lin, Xiaofeng, et al.. (2020). Concurrent inhibition of ErbB family and MEK/ERK kinases to suppress non-small cell lung cancer proliferation.. PubMed. 12(3). 847–856. 5 indexed citations
9.
Liao, Jipei, Jun Shen, Qixin Leng, et al.. (2020). MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC). Thoracic Cancer. 11(3). 762–768. 39 indexed citations
10.
Yang, Zejia, Jipei Liao, Brandon Carter‐Cooper, et al.. (2019). Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer. 19(1). 485–485. 32 indexed citations
11.
Lin, Xiaofeng, Jipei Liao, Zejia Yang, et al.. (2019). Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.. PubMed. 9(6). 1282–1292. 16 indexed citations
12.
Li, Zhipeng, Jipei Liao, Zejia Yang, et al.. (2018). Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer. 120(3). 306–316. 13 indexed citations
13.
Wang, Xiaoying, Jing Wang, Miao Li, et al.. (2018). Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expression. OncoTargets and Therapy. Volume 11. 1173–1182. 9 indexed citations
14.
Mannoor, Kaiissar, Jun Shen, Jipei Liao, Zhenqiu Liu, & Feng Jiang. (2014). Small nucleolar RNA signatures of lung tumor-initiating cells. Molecular Cancer. 13(1). 104–104. 75 indexed citations
15.
Shen, Jun, Jipei Liao, Maria Guarnera, et al.. (2013). Analysis of MicroRNAs in Sputum to Improve Computed Tomography for Lung Cancer Diagnosis. Journal of Thoracic Oncology. 9(1). 33–40. 82 indexed citations
16.
Mannoor, Kaiissar, Jipei Liao, & Feng Jiang. (2012). Small nucleolar RNAs in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1826(1). 121–128. 125 indexed citations
17.
Shen, Jun, Ziling Liu, Nevins W. Todd, et al.. (2011). Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer. 11(1). 374–374. 217 indexed citations
18.
Liao, Jipei, Lei Yu, Yuping Mei, et al.. (2010). Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Molecular Cancer. 9(1). 198–198. 216 indexed citations
19.
Shen, Jun, Nevins W. Todd, Howard Zhang, et al.. (2010). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory Investigation. 91(4). 579–587. 318 indexed citations
20.
Liao, Jipei, et al.. (2001). [Antisense RNA for urokinase receptor inhibits the invasiveness and metastasis of lung carcinoma].. PubMed. 30(5). 357–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Fabris Breakdown of academic impact, for papers by Zhi‐Xuan Li Breakdown of academic impact, for papers by Anna Sanchez Calle Breakdown of academic impact, for papers by Wataru Okajima Breakdown of academic impact, for papers by Verónica Torrano Breakdown of academic impact, for papers by Yuanhe Wang Breakdown of academic impact, for papers by Mahito Miyamae Breakdown of academic impact, for papers by Anna Aakula Breakdown of academic impact, for papers by Mengying Cui
Rankless by CCL
2026